Rubius Therapeutics, Inc. Gains 84.36%

Mon, Mar 15, 2021 at 05:30 PM

Rubius Therapeutics, Inc. (RUBY:NASDAQ) rocketted at $30.29, a gain of 84.4%. On Fri 12 Mar 21, RUBY:NASDAQ hit a New 2-Week High of $16.43. The stock got featured on our News Catalysts scanner on Mon 15 Mar 21 at 05:10 PM in the 'PUBLIC OFFERING' category. From Fri 26 Feb 21, the stock recorded 50.00% Up Days and 72.73% Green Days

About Rubius Therapeutics, Inc. (RUBY:NASDAQ)

Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Top 10 Gainers:

Sigma Labs, Inc. (SGLB:NASDAQ), 128.74%
OCG (OCG:NASDAQ), 120.38%
Takung Art Co., Ltd. (TKAT:NYSEMKT), 105.13%
Check-Cap Ltd. (CHEK:NASDAQ), 100.65%
IGNY (IGNY:NASDAQ), 100%
Rubius Therapeutics, Inc. (RUBY:NASDAQ), 84.36%
Luokung Technology Corp. (LKCO:NASDAQ), 55.66%
Zynerba Pharmaceuticals, Inc. (ZYNE:NASDAQ), 49.26%
Liquid Media Group Ltd. (YVR:NASDAQ), 46.7%
Shaw Communications Inc. (SJR:NYSE), 41.37%